FANAX
Price
$44.06
Change
-$0.37 (-0.83%)
Updated
Dec 17 closing price
RYVCX
Price
$177.00
Change
-$2.18 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

FANAX vs RYVCX

Header iconFANAX vs RYVCX Comparison
Open Charts FANAX vs RYVCXBanner chart's image
Fidelity Advisor Energy A
Price$44.06
Change-$0.37 (-0.83%)
VolumeN/A
CapitalizationN/A
Rydex Energy Services C
Price$177.00
Change-$2.18 (-1.22%)
VolumeN/A
CapitalizationN/A
FANAX vs RYVCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FANAX vs. RYVCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FANAX is a Sell and RYVCX is a StrongSell.

FUNDAMENTALS
Fundamentals
FANAX has more cash in the bank: 1.24B vs. RYVCX (6.57M). FANAX pays higher dividends than RYVCX: FANAX (1.79) vs RYVCX (0.00). FANAX was incepted earlier than RYVCX: FANAX (28 years) vs RYVCX (24 years). RYVCX is a more actively managed with annual turnover of: 242.00 vs. FANAX (21.00). FANAX has a lower initial minimum investment than RYVCX: FANAX (0) vs RYVCX (2500). FANAX annual gain was more profitable for investors over the last year : 3.23 vs. RYVCX (-8.23). FANAX return over 5 years is better than : 75.75 vs. RYVCX (-1.93).
FANAXRYVCXFANAX / RYVCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD3.233-9.016-36%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B6.57M18,919%
Annual Yield % from dividends1.790.00-
Returns for 1 year3.23-8.23-39%
Returns for 3 years75.7236.11210%
Returns for 5 years75.75-1.93-3,925%
Returns for 10 years38.19-68.22-56%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMAB20.030.01
+0.05%
Genmab A/S ADS
ULBI7.76-0.06
-0.77%
Ultralife Corp
MTRN106.57-1.57
-1.45%
Materion Corp
CGEM11.49-0.31
-2.63%
Cullinan Therapeutics
CISS0.67-0.03
-3.74%
C3is